ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1821

Benefits Of Progressive Muscle Strengthening Using a Swiss Ball In Patients With Ankylosing Spondylitis: A Randomized Controlled Trial

Marcelo Souza1, Fabio Jennings2, Hisa Morimoto1 and Jamil Natour3, 1Division of Rheumatology, Universidade Federal de Sao Paulo, Sao Paulo, Brazil, 2Rheumatology Division, Universidade Federal de Sao Paulo, Sao Paulo, Brazil, 3Rheumatology, Universidade Federal de São Paulo, São Paulo, Brazil

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS), exercise, functional status, strength and treatment

  • Tweet
  • Email
  • Print
Session Information

Title: Rehabilitation Sciences

Session Type: Abstract Submissions (ARHP)

Background/Purpose:

Ankylosing spondylitis (AS) is a systemic inflammatory disease that affects the physical capacity of patients globally. Exercises are recommended to the management of patients with AS, although the benefits of specific exercise programs are not yet well defined.

Objective: To evaluate the effectiveness of a progressive muscle strengthening program using a Swiss ball in improving functional capacity, muscle strength, disease activity, mobility and quality of life of patients with AS.

Methods:

Sixty patients were randomized to intervention group (IG) or to control group (CG), with 30 patients in each group. Eight exercises were done by GI with free weights on a Swiss ball, 2 times per week for 16 weeks. Loads were reassessed and increased every 4 weeks. The GC continued drug therapy without any exercise, on a waiting list. The evaluations were performed by a blinded evaluator immediately before randomization and at 4, 8, 12 and 16 weeks after initiation of the study. Functional capacity were evaluated using the BASFI (Bath Ankylosing Spondylitis Functional The Index), HAQ-S (Health Assessment Questionnaire for Spondyloarthropathies), the 6-minute walk test and the Time Up and Go test. Muscle strength was assessed by the 1-repetition maximum (1 RM) test. Disease activity was measured by BASDAI (The Bath Ankylosing Spondylitis Disease Activity Index) and by dosage of ESR and C-reactive protein. The BASMI (The Bath Ankylosing Spondylitis Metrologyl Index) was used to assess spinal mobility and the SF-36 questionnaire to assess quality of life. Patients were also evaluated by Likert scale for satisfaction. In addition, the amount of analgesic and non-steroidal anti-inflammatory used was controlled.

Results:

The groups were homogeneous at baseline for clinical and demographic characteristics. There was a statistically significant difference between the two groups in the improvement of strength in IG compared to the CG for the muscles used in the exercises: abdominal (p = 0.003), unilateral stroke (p = 0.02), squat (p = 0.01), triceps (p = 0.021) and reverse crucifix (p = 0.02). The IG also improved the 6-minute walk test (p = 0.005) at week 16 compared with the CG. We also found a statistically significant difference between groups in the Likert scale at all times (p <0.001) with IG showing greater treatment satisfaction. We found no differences between groups in other variables and there was no worsening of disease activity in IG.

Conclusion:

The progressive muscle strengthening using a Swiss ball is effective in improving muscle strength and walking performance in patients with AS. The exercise program has shown good tolerance assessed by patient satisfaction without deleterious effects on disease activity.


Disclosure:

M. Souza,
None;

F. Jennings,
None;

H. Morimoto,
None;

J. Natour,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/benefits-of-progressive-muscle-strengthening-using-a-swiss-ball-in-patients-with-ankylosing-spondylitis-a-randomized-controlled-trial/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology